InvestorsHub Logo
Followers 467
Posts 26917
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 88

Tuesday, 01/07/2014 5:51:24 PM

Tuesday, January 07, 2014 5:51:24 PM

Post# of 138
9:05AM Supernus Pharma announces issuance of third US patent protecting oxtellar XR (SUPN) 8.11 : Co announced the issuance of a third patent (number 8,617,600) by the United States Patent and Trademark Office (USPTO) covering Oxtellar XR, its novel once-daily extended-release oxcarbazepine product.

The patent was issued by the USPTO on December 31, 2013. It provides protection for the product with expiration that is no earlier than 2027. Supernus has several additional patent applications for extended-release topiramate and extended-release oxcarbazepine pending in other geographic regions

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SUPN News